Cargando…
Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial
Background: Contrast-associated acute kidney injury (CA-AKI) is still a major concern for referring physicians, especially in the setting of ST-elevation myocardial infarction (STEMI) patients undergoing primary-PCI (pPCI). To evaluate whether glutathione sodium salt (GSS) infusion impacts favorably...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304815/ https://www.ncbi.nlm.nih.gov/pubmed/37374173 http://dx.doi.org/10.3390/life13061391 |
_version_ | 1785065592815878144 |
---|---|
author | Arrivi, Alessio Pucci, Giacomo Sordi, Martina Dominici, Marcello Barillà, Francesco Carnevale, Roberto Morgantini, Amalia Rosati, Riccardo Mangieri, Enrico Tanzilli, Gaetano |
author_facet | Arrivi, Alessio Pucci, Giacomo Sordi, Martina Dominici, Marcello Barillà, Francesco Carnevale, Roberto Morgantini, Amalia Rosati, Riccardo Mangieri, Enrico Tanzilli, Gaetano |
author_sort | Arrivi, Alessio |
collection | PubMed |
description | Background: Contrast-associated acute kidney injury (CA-AKI) is still a major concern for referring physicians, especially in the setting of ST-elevation myocardial infarction (STEMI) patients undergoing primary-PCI (pPCI). To evaluate whether glutathione sodium salt (GSS) infusion impacts favorably on CA-AKI, an unplanned exploratory data analysis of the GSH 2014 trial was performed. Methods: One hundred patients with STEMI were assigned at random to an experimental group (No. 50) or to a placebo group (No. 50). Treatment consisted of an intravenous infusion of GSS lasting over 10 min before p-PCI. The placebo group received the same quantity of normal saline solution. After the interventions, glutathione was administered in the same doses to both groups at 24, 48 and 72 h. Results: CA-AKI occurred in 5 out of 50 patients (10%) allocated to the experimental group (GSS infusion) and in 19 out of 50 patients (38%) allocated to the placebo group (p between groups < 0.001). No patients in either group required renal replacement therapy. After allowing for multiple confounders, GSS administration (OR 0.17, 95% CI 0.04–0.61) and door-to-balloon time (in hours) (OR 1.61, 95% CI 1.01–2.58) have been the only independent predictors of CA-AKI. Conclusions: the results of this sub-study, which show a significant trend towards an improved nephroprotection in the experimental group, led to the hypothesis of a possible new prophylactic approach to counteract CA-AKI using repeated GSS infusion. Subsequent studies with specific clinical outcomes would be necessary to confirm these data. |
format | Online Article Text |
id | pubmed-10304815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103048152023-06-29 Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial Arrivi, Alessio Pucci, Giacomo Sordi, Martina Dominici, Marcello Barillà, Francesco Carnevale, Roberto Morgantini, Amalia Rosati, Riccardo Mangieri, Enrico Tanzilli, Gaetano Life (Basel) Brief Report Background: Contrast-associated acute kidney injury (CA-AKI) is still a major concern for referring physicians, especially in the setting of ST-elevation myocardial infarction (STEMI) patients undergoing primary-PCI (pPCI). To evaluate whether glutathione sodium salt (GSS) infusion impacts favorably on CA-AKI, an unplanned exploratory data analysis of the GSH 2014 trial was performed. Methods: One hundred patients with STEMI were assigned at random to an experimental group (No. 50) or to a placebo group (No. 50). Treatment consisted of an intravenous infusion of GSS lasting over 10 min before p-PCI. The placebo group received the same quantity of normal saline solution. After the interventions, glutathione was administered in the same doses to both groups at 24, 48 and 72 h. Results: CA-AKI occurred in 5 out of 50 patients (10%) allocated to the experimental group (GSS infusion) and in 19 out of 50 patients (38%) allocated to the placebo group (p between groups < 0.001). No patients in either group required renal replacement therapy. After allowing for multiple confounders, GSS administration (OR 0.17, 95% CI 0.04–0.61) and door-to-balloon time (in hours) (OR 1.61, 95% CI 1.01–2.58) have been the only independent predictors of CA-AKI. Conclusions: the results of this sub-study, which show a significant trend towards an improved nephroprotection in the experimental group, led to the hypothesis of a possible new prophylactic approach to counteract CA-AKI using repeated GSS infusion. Subsequent studies with specific clinical outcomes would be necessary to confirm these data. MDPI 2023-06-14 /pmc/articles/PMC10304815/ /pubmed/37374173 http://dx.doi.org/10.3390/life13061391 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Arrivi, Alessio Pucci, Giacomo Sordi, Martina Dominici, Marcello Barillà, Francesco Carnevale, Roberto Morgantini, Amalia Rosati, Riccardo Mangieri, Enrico Tanzilli, Gaetano Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial |
title | Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial |
title_full | Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial |
title_fullStr | Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial |
title_full_unstemmed | Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial |
title_short | Repeated Glutathione Sodium Salt Infusion May Counteract Contrast-Associated Acute Kidney Injury Occurrence in ST-Elevation Myocardial Infarction Patients Undergoing Primary PCI: A Randomized Subgroup Analysis of the GSH 2014 Trial |
title_sort | repeated glutathione sodium salt infusion may counteract contrast-associated acute kidney injury occurrence in st-elevation myocardial infarction patients undergoing primary pci: a randomized subgroup analysis of the gsh 2014 trial |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304815/ https://www.ncbi.nlm.nih.gov/pubmed/37374173 http://dx.doi.org/10.3390/life13061391 |
work_keys_str_mv | AT arrivialessio repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT puccigiacomo repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT sordimartina repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT dominicimarcello repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT barillafrancesco repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT carnevaleroberto repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT morgantiniamalia repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT rosatiriccardo repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT mangierienrico repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial AT tanzilligaetano repeatedglutathionesodiumsaltinfusionmaycounteractcontrastassociatedacutekidneyinjuryoccurrenceinstelevationmyocardialinfarctionpatientsundergoingprimarypciarandomizedsubgroupanalysisofthegsh2014trial |